Shares of Select Medical Holdings Co. (NYSE:SEM) have been given a consensus recommendation of “Hold” by the eleven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $19.50.
A number of research analysts recently commented on SEM shares. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Deutsche Bank reiterated a “buy” rating and set a $22.00 price objective on shares of Select Medical in a research note on Monday, November 6th. Royal Bank of Canada reiterated a “buy” rating and set a $19.00 price objective on shares of Select Medical in a research note on Wednesday, September 13th. Robert W. Baird set a $25.00 price objective on shares of Select Medical and gave the company a “buy” rating in a research note on Monday, October 23rd. Finally, Zacks Investment Research lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th.
In related news, insider Michael E. Tarvin sold 18,500 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $18.97, for a total transaction of $350,945.00. Following the completion of the sale, the insider now directly owns 340,044 shares in the company, valued at $6,450,634.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Martin F. Jackson sold 156,603 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $17.06, for a total transaction of $2,671,647.18. Following the sale, the insider now owns 1,790,601 shares of the company’s stock, valued at $30,547,653.06. The disclosure for this sale can be found here. Insiders have sold 314,455 shares of company stock valued at $5,403,144 over the last 90 days. 19.93% of the stock is currently owned by insiders.
Large investors have recently modified their holdings of the stock. Pacad Investment Ltd. boosted its stake in Select Medical by 58.7% in the 2nd quarter. Pacad Investment Ltd. now owns 7,300 shares of the health services provider’s stock worth $112,000 after purchasing an additional 2,700 shares during the period. PNC Financial Services Group Inc. boosted its stake in Select Medical by 4.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock worth $133,000 after purchasing an additional 396 shares during the period. Riverhead Capital Management LLC boosted its stake in Select Medical by 78.0% in the 2nd quarter. Riverhead Capital Management LLC now owns 8,722 shares of the health services provider’s stock worth $134,000 after purchasing an additional 3,822 shares during the period. Flinton Capital Management LLC boosted its stake in Select Medical by 75.8% in the 2nd quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock worth $150,000 after purchasing an additional 4,200 shares during the period. Finally, Shelton Capital Management acquired a new position in Select Medical in the 2nd quarter worth approximately $164,000. Hedge funds and other institutional investors own 77.89% of the company’s stock.
Shares of Select Medical (NYSE:SEM) traded down $0.25 during trading hours on Monday, hitting $17.25. 568,300 shares of the company’s stock traded hands, compared to its average volume of 910,500. Select Medical has a 12 month low of $12.00 and a 12 month high of $19.77. The firm has a market capitalization of $2,310.00, a price-to-earnings ratio of 23.96, a P/E/G ratio of 1.18 and a beta of 1.34. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 3.36.
Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The company had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the prior year, the business earned $0.06 EPS. Select Medical’s revenue was up 4.1% compared to the same quarter last year. sell-side analysts anticipate that Select Medical will post 0.86 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Brokerages Set Select Medical Holdings Co. (SEM) Price Target at $19.50” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/18/brokerages-set-select-medical-holdings-co-sem-price-target-at-19-50.html.
About Select Medical
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.